Actifs pris en charge
WWc logo

WW International

24/7

Ouvrir Mo

-

-sur la période sélectionnée

Dernière clôture
12,98 $US
Prime / décote
-
Mis à jour Référence Yahoo Finance ·

Écarts de prix avant frais et coûts d’exécution. Comparer les prix

Analyses

WW debate centers on GLP-1's hit to behavioral demand. Turnaround hopes rest on clinical growth and repairs.

GLP-1 demand shift versus clinical growth

WW's clinical segment integrating GLP-1 medications reported revenue up 30.4% annually, and clinical subscribers increased nearly 56% in the second quarter. WW introduced GLP-1 Success and menopause-focused programs within Core+. This supports a pivot toward medication-linked care.

Rising consumer use of GLP-1 weight-loss drugs is still pressuring demand for WW's legacy behavioral diet programs. WW's Q2 2026 legacy behavioral revenue was down 22.7% year-over-year. Investors appear to be staying focused on that longer-run demand shift.

WW International Reports Q2 2026 Earnings: Strong EPS Beat, Clinical Growth, and Guidance Reaffirmed - WW News - EveryTickerGLP-1 Integration Meets Balance Sheet Repair: WeightWatchers' Post-Bankruptcy Pivot (NASDAQ:WW) - WW Analysis - EveryTickerWW International Eyes Cash Flow Turnaround as GLP-1 Care Gains Momentum - Daily PoliticalWhy WeightWatchers (WW) Stock Is Falling TodayWW International Reports Q2 2026 Earnings: Strong EPS Beat, Clinical Growth, and Guidance Reaffirmed - WW News - EveryTickerGLP-1 Integration Meets Balance Sheet Repair: WeightWatchers' Post-Bankruptcy Pivot (NASDAQ:WW) - WW Analysis - EveryTicker

Google Health and employer wellness partnerships

WW announced a collaboration with Google Health Enterprise, giving eligible members in select employer programs access to Google Fitbit Air and Google Health Premium. Investing.com reported that analysts view multi-layered partnerships as crucial catalysts that could rebuild subscriber momentum.

Investors appear to be treating the Google news as incremental while staying focused on longer-run demand shift. The tech tie-up supports engagement in the GLP-1 era, but it does not erase the structural hit to traditional behavioral subscriptions.

Wall Street eyes WW International recovery following bullish Northland initiation By Investing.comWhy is WW International stock surging today? By Investing.comWhy WeightWatchers (WW) Stock Is Falling Today

Balance-sheet reset versus leadership uncertainty

The 2025 Chapter 11 restructuring eliminated over $1.1 billion in debt, reducing the term loan from $1.6 billion to $423.6 million and leaving $101.5 million in unrestricted cash. WW expects to be free-cash-flow positive this year, and adjusted gross margins were above 73%.

The March 2026 CEO departure and ongoing search for a permanent replacement create uncertainty. Failure to appoint leadership with healthcare and consumer subscription experience could impact scaling clinical operations. The restructuring initially triggered a steep sell-off and subsequent NASDAQ delisting.

WW International Reports Q2 2026 Earnings: Strong EPS Beat, Clinical Growth, and Guidance Reaffirmed - WW News - EveryTickerGLP-1 Integration Meets Balance Sheet Repair: WeightWatchers' Post-Bankruptcy Pivot (NASDAQ:WW) - WW Analysis - EveryTickerWW International Eyes Cash Flow Turnaround as GLP-1 Care Gains Momentum - Daily PoliticalWall Street eyes WW International recovery following bullish Northland initiation By Investing.comWW International Reports Q2 2026 Earnings: Strong EPS Beat, Clinical Growth, and Guidance Reaffirmed - WW News - EveryTickerGLP-1 Integration Meets Balance Sheet Repair: WeightWatchers' Post-Bankruptcy Pivot (NASDAQ:WW) - WW Analysis - EveryTicker

Token

Token
WWc
Actions par token
1.00000000 WW
Contrat
0xb20000000000000000000089221e238277d52515

Obtenir Mo